Top 5 AI Clinical Trials Companies

Published: August 2026

AI in clinical trials represents a significant advancement in drug development precision and efficiency. It leverages machine learning algorithms and predictive analytics to optimize trial protocols. This data driven approach identifies suitable patient cohorts accelerates recruitment timelines and enhances outcome predictions compared to conventional manual methods.

AI addresses key challenges of traditional clinical trials such as prolonged recruitment periods and high failure rates. One primary reason is its ability to analyze vast datasets from electronic health records and real-world evidence to match patients more accurately. This reduces enrollment delays and improves trial success probabilities. Secondly, it involves adaptive trial designs enabled by real time data monitoring which allows mid study adjustments to dosing or endpoints minimizing resource waste.

This has attracted numerous startups driven by breakthroughs in natural language processing and AI in digital genome applications for protocol automation, alongside substantial investor interest in AI-powered solutions for faster regulatory approvals. Over recent years, several new AI developers have entered the market, focusing on innovative platforms to address unmet needs in oncology trials and broader therapeutic areas.

Roots Analysis has conducted an exhaustive study on AI in Clinical Trials Market featuring the current market landscape and future opportunities for companies engaged in healthcare, over a span of next 9 years.

Top Five AI Clinical Trials Companies

Clarivate
Concert AI
IQVIA
LabCorp
Medidata

The figure below highlights the top five AI clinical trials companies:

Top Companies offering AI for Utilization in Clinical Trials

Interested in exploring all ~135 players offering software and services for AI in clinical trials, along with their recent initiatives?

Discover Below the Details on Top 5 AI Clinical Trials Companies

Let us dive deep into the details of the top 5 companies offering software and services for AI in clinical trials. It is essential to note that the selection of top players can differ substantially according to the defined criteria.

1. Clarivate

Company Overview

Clarivate is a UK-based company offering transformative intelligence and insights in various fields, such as life sciences and healthcare, intellectual property, academia and government. With the launch of Cortellis Digital Health Intelligence in 2019, the company offers intelligent solutions which are both virtual and consumer centric, aiding both healthcare professionals and patients for navigating the digital health landscape.

Clarivate: Company Overview

	Company Name	Year of Establishment	Headquarters	Number of Employees
	Clarivate	2016	UK	10,000+

Recent Developments

In January 2026, the company entered into a collaboration with the Ministry of Higher Education and Scientific Research in Iraq highlighting its AI driven clinical trial platform capabilities. This partnership focuses on deploying advanced machine learning models to streamline patient recruitment and optimize trial data analysis for national research initiatives.

To know more about the recent initiatives of Clarivate and other AI clinical trials companies, access full report.

2. ConcertAI

Company Overview

ConcertAI is a well-renowned company in the field of AI which has more than 200 AI and data science data aggregation professionals and more than 450 curation experts. The company offers Digital Trial Solutions platform, an end-to-end digital platform which combines real-world data, site-level insights and advanced automation, which will eventually transform clinical trial operations. The company’s core capabilities include study design and optimization, site feasibility and selection, and patient matching.

ConcertAI: Company Overview

	Company Name	Year of Establishment	Headquarters	Number of Employees
	Concert AI	2018	US	1,001-5,000

Recent Developments

In January 2026, ConcertAI entered into a collaboration with Foundation Medicine highlighting the integration of multimodal genomic data with extensive real world clinical datasets. This partnership combines Foundation Medicine’s comprehensive genomic testing insights with ConcertAI’s AI powered clinical data platform to create one of the largest clinically linked datasets for life sciences research.

To know more about the recent initiatives of ConcertAI and other AI clinical trials companies, access full report.

3. IQVIA

Company Overview

IQVIA offers advanced analytics, clinical research services, and technology solutions to the healthcare industry, employing over 80,000 clinicians and data scientists across more than 100 countries. The firm focuses on accelerating drug development, enhancing commercial efficacy, maintaining product quality and safety, and improving healthcare access. Furthermore, IQVIA provides clinical trial platforms and associated services by leveraging machine learning, data science, deep learning algorithms, and AI in computer vision. By harnessing the capabilities of IQVIA Connected Intelligence, the company accelerates patient identification and enrollment, eliminates cost-related obstacles, and reduces site burden.

IQVIA: Company Overview

	Company Name	Year of Establishment	Headquarters	Number of Employees
	IQVIA	1982	US	10,000+

Recent Developments

In March 2026, IQVIA unveiled IQVIA.ai, a unified agentic AI platform powered by NVIDIA, designed to enhance efficiency and decision-making across life sciences. Built on IQVIA’s Healthcare-grade AI, proprietary data assets, and deep domain expertise, the platform enables life sciences organizations to embed intelligence into clinical, commercial, and real-world workflows. It supports secure, compliant AI adoption at scale, with intelligent agents that help accelerate research, streamline operations, and improve decision support.

To know more about the recent initiatives of IQVIA and other AI clinical trials companies, access full report.

4. LabCorp

Company Overview

LabCorp is a global life science company which offers expertise in central lab services across various disciplines, such as cell and gene therapy, genomics, bioanalytical, clinical trial enablement and companion diagnostics. The company specializes in AI-powered pathology and comprehensive clinical reporting tools, which support innovative solutions. For healthcare professionals, the company offers data modelling and reports, data and insight reporting, and bidirectional interfaces. Whereas, for the sponsors and researchers, the company provides pharmacometrics and in-silico models, Xcellerate (a clinical trial management suite of applications) and AI modelling services.

Labcorp: Company Overview

	Company Name	Year of Establishment	Headquarters	Number of Employees
	Labcorp	1995	US	10,000+

Recent Developments

In April 2026, Labcorp introduced an AI-powered real-world data platform developed with AWS and Datavant to accelerate Alzheimer’s research. The platform combines Labcorp’s extensive diagnostic and genomic datasets with medical claims and other privacy-protected healthcare data, leveraging agentic AI and advanced analytics to enable rapid insights, patient cohort identification, and clinical trial recruitment. By compressing months of data preparation into minutes, it aims to shorten drug development timelines and support faster scientific discovery for Alzheimer’s and related conditions.

To know more about the recent initiatives of Labcorp and other AI clinical trials companies, access full report.

5. Medidata

Company Overview

Medidata is a US-based software development company focused on providing offerings pertaining to digital transformation in the field of pharmaceutical, biotech, MedTech and diagnostics domain. Notably, the offerings include clinical data management and analytics, patient engagement, clinical trial design and management, healthcare and therapeutic solutions and other professional services. Company’s unified clinical trial platform, which is based on AI and automation, has been designed in order to offer extensive capabilities in terms of patient, data and clinical study experience. This is achievable through the amalgamation of digital technologies, which aids in offering actionable insights and optimization of the study design.

Medidata: Company Overview

	Company Name	Year of Establishment	Headquarters	Number of Employees
	Medidata	1999	US	1,001 - 5,000

Recent Developments

In July 2026, Medidata launched Medidata Plus, an AI-native foundation designed to scale clinical portfolios. This clinical artificial intelligence layer unlocks scalable, outcome-driven AI capabilities across the Medidata Platform, enabling sponsors and CROs to move beyond fragmented point solutions toward a unified, end-to-end AI strategy. By standardizing the data layer across the clinical trial lifecycle, Medidata Plus accelerates study builds, enables no-code data transformation, supports proactive de-risking, and delivers real-time insights to improve trial efficiency, quality, and speed to market.

To know more about Medidata and other AI clinical trials companies, access full report.

What About Other Companies Offering AI Software and Services Around the World?

The above article features the top five AI in clinical trials companies selected from a pool of around 135 companies that we have compiled. If you're interested, you can download the Sample Report on this topic by Roots Analysis. For personalized assistance in identifying the most relevant solutions based on your specific criteria, please don't hesitate to reach out to us at sales@rootsanalysis.com.

Sources: